IndieBio SF’s Second Cohort of Biotech Startups
demoday.indiebio.co
demoday.indiebio.co
Myi might have interesting tech, because I trust their cto... But I'm honestly not sure about the other folks involved, in any case diagnostics is going to be very very hard in the next few years.
I'm not harshing on class 1 - probably even with ycombinator, many classes if not all are "mostly crap". Zero, though, is stunning.
https://sosv.com/why-pembient-is-confident-in-synthetic-rhin...
As for IndieBio and the prospects of its class members, I'm sure it is too early to tell. We're flattered, though, to be included in this discussion.
I don't think you can order them, but if you think you're going to be doing computation with neurons, you're an idiot. It'll be overhead like a d-wave, except with zero mathematically validated acceleration instead of maybe making a trip into a small corner of NP.
Please read what I wrote carefully, I said I can order assays. This is koniku's primary market (pharma paying for assays), but they're way behind. Without this source of revenue, they won't be competitive.